常见的成年人食热症形式需要增加的外科手术剂量
Veronika Yehezkeli1, Joseph L Demer2
1From the Stein Eye Institute and Department of Ophthalmology (V.Y.), University of California, Los Angeles, California, USA.
American journal of ophthalmology
|February 13, 2025
概括
在年轻的成年人中,手术纠正缺食的缺食症 (脱补食症) 是常见的. 需要增加中间直肠衰退的剂量,以防止这些患者和与年龄相关的远距离内分泌症的老年人复发.
科学领域:
- 眼科医生 眼科 眼科
- 眼 手术 整形外科
- 视觉运动学是指眼动运动学.
背景情况:
- 与年龄相关的距离精力衰竭 (ARDE) 往往源于眼综合征.
- 脱补食食症 (decompensated esophoria,DE) 是一种在年轻人中出现的渐进性食食症.
- 评估中枢直肠 (MR) 衰退的手术剂量至关重要,以防止DE和ARDE的不足纠正.
研究的目的:
- 评估中间直肠 (MR) 衰退剂量是否需要超过治疗失补助性食道症 (DE) 和与年龄相关的距离食道症 (ARDE) 的标准建议.
- 为了比较DE和ARDE患者之间的手术结果和复发率.
主要方法:
- 一个比较的干预病例系列分析了从2015年到2024年的眼手术数据.
- 54名DE和61名ARDE患者的双边MR衰退手术与帕克斯的表格进行了比较.
- 与MR衰退剂量相比,分析了手术效应和复发率.
主要成果:
- 在手术前的食otropia 在DE (21 ± 10Δ) 显著高于ARDE (14 ± 9Δ).
- 在3年内,在22%的ED患者中复发,明显高于ARDE患者.
- 增加的MR衰退改善了调整,但效果不如帕克斯表所预测的,特别是在德意志.
结论:
- 标准MR衰退剂量对于ARDE来说是足够的.
- 对于DE,必须进一步增加中间直肠衰退的剂量,以防止不足的纠正和早期的复发.
- 对DE的最佳外科剂量进行进一步研究是有必要的.
相关概念视频
01:28Angle Closure Glaucoma: Treatment
432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
01:27Open Angle Glaucoma: Treatment
386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
386